Sagimet Biosciences Inc. (SGMT) KPIs and segments

SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30

$10.22−0.71 (-6.50%)

Close on Nov 13, 2026Market cap $635.26MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Sagimet Biosciences's business

Coming soon

This tab will track the numbers specific to Sagimet Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?